Cargando…
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
Medication-related osteonecrosis of the jaw (MRONJ) has become a well-known side effect of antiresorptive, and antiangiogenic drugs commonly used in cancer management. Despite a considerable amount of literature addressing MRONJ, it is still widely accepted that the underlying pathomechanism of MRON...
Autores principales: | Otto, Sven, Aljohani, Suad, Fliefel, Riham, Ecke, Sara, Ristow, Oliver, Burian, Egon, Troeltzsch, Matthias, Pautke, Christoph, Ehrenfeld, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151678/ https://www.ncbi.nlm.nih.gov/pubmed/34065104 http://dx.doi.org/10.3390/medicina57050463 |
Ejemplares similares
-
Fluorescence-guided surgery for osteoradionecrosis of the jaw: a
retrospective study
por: Aljohani, Suad, et al.
Publicado: (2022) -
Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report
por: Otto, Sven, et al.
Publicado: (2011) -
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
por: Wick, Alexander, et al.
Publicado: (2021) -
Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016) -
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)